We are live on ! Find out more
CTA

Chesley Taft & Associates Portfolio holdings

AUM $2.57B
1-Year Est. Return 22.93%
This Fund
S&P 500
This Quarter Est. Return
+4.39%
1 Year Est. Return
+22.93%
3 Year Est. Return
+80.85%
5 Year Est. Return
+97.37%
10 Year Est. Return
+353.09%
AUM
$967M
AUM Growth
+$34.1M
Cap. Flow
+$3.02M
Cap. Flow %
0.31%
Top 10 Hldgs %
21.2%
Holding
258
New
9
Increased
107
Reduced
75
Closed
9

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$12.7M
2
NXPI icon
NXP Semiconductors
NXPI
+$7.19M
3
MET icon
MetLife
MET
+$5.66M
4
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$2.39M
5
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$1.8M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$7.68M
2
KO icon
Coca-Cola
KO
+$6.98M
3
EMC
EMC CORPORATION
EMC
+$5.89M
4
WBA
Walgreens Boots Alliance
WBA
+$2.75M
5
ECYT
Endocyte, Inc. Common Stock
ECYT
+$2.52M

Sector Composition

Rank Sector Weight
1 Healthcare 20.02%
2 Industrials 15.05%
3 Technology 12.15%
4 Consumer Staples 9.68%
5 Energy 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
26
Apple
AAPL
$4.9T
$10.8M 1.12%
466,412
-13,480
-3% -$287K
MSFT icon
27
Microsoft
MSFT
$3.35T
$10.6M 1.1%
254,726
-454
-0.2% -$18.4K
ORCL icon
28
Oracle
ORCL
$367B
$10.5M 1.09%
260,081
-4,715
-2% -$194K
JCI icon
29
Johnson Controls International
JCI
$87.2B
$10.4M 1.07%
198,405
-1,242
-0.6% -$61.8K
SPY icon
30
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$10.2M 1.06%
52,235
+1,678
+3% +$319K
SYK icon
31
Stryker
SYK
$133B
$10.2M 1.05%
120,773
-1,325
-1% -$108K
KO icon
32
Coca-Cola
KO
$381B
$10.1M 1.05%
239,310
-172,021
-42% -$6.98M
INTC icon
33
Intel
INTC
$460B
$10.1M 1.04%
327,039
-4,166
-1% -$114K
VZ icon
34
Verizon
VZ
$193B
$9.89M 1.02%
202,202
+24,827
+14% +$1.2M
MCK icon
35
McKesson
MCK
$101B
$9.81M 1.01%
52,699
-300
-0.6% -$53.4K
LKQ icon
36
LKQ Corp
LKQ
$5.76B
$9.61M 0.99%
359,917
+7,815
+2% +$216K
MET icon
37
MetLife
MET
$62.5B
$9.38M 0.97%
189,398
+120,984
+177% +$5.66M
PFE icon
38
Pfizer
PFE
$142B
$9.12M 0.94%
323,922
-6,572
-2% -$187K
CHD icon
39
Church & Dwight Co
CHD
$23.1B
$9.12M 0.94%
260,620
-300
-0.1% -$10.3K
QCOM icon
40
Qualcomm
QCOM
$159B
$8.88M 0.92%
112,153
+723
+0.6% +$57.5K
CVS icon
41
CVS Health
CVS
$134B
$8.32M 0.86%
110,418
+2,130
+2% +$161K
CBI
42
DELISTED
Chicago Bridge & Iron Nv
CBI
$8.1M 0.84%
118,690
+335
+0.3% +$26.6K
WFC icon
43
Wells Fargo
WFC
$258B
$8.07M 0.83%
153,462
+15,264
+11% +$767K
BAX icon
44
Baxter International
BAX
$13.8B
$7.9M 0.82%
201,269
+4,971
+3% +$199K
NXPI icon
45
NXP Semiconductors
NXPI
$61.8B
$7.77M 0.8%
+117,465
New +$7.19M
CTSH icon
46
Cognizant
CTSH
$24.3B
$7.73M 0.8%
158,082
-2,287
-1% -$111K
SLB icon
47
SLB Ltd
SLB
$72.6B
$7.69M 0.79%
65,187
+274
+0.4% +$28.2K
TMO icon
48
Thermo Fisher Scientific
TMO
$214B
$7.67M 0.79%
65,015
+520
+0.8% +$61.2K
SBUX icon
49
Starbucks
SBUX
$121B
$7.64M 0.79%
197,500
-400
-0.2% -$14.5K
OXY icon
50
Occidental Petroleum
OXY
$55.6B
$7.58M 0.78%
77,059
+2,648
+4% +$249K
1
2
3 4 5

Similar funds

GWP
Gateway Wealth Partners Appleton, Wisconsin $2.57B AUM 16.81% 1-Year Est. Return
PCM
Palestra Capital Management New York $2.57B AUM 29.93% 1-Year Est. Return
DCM
Dorsal Capital Management Redwood City, California $2.57B AUM 3.13% 1-Year Est. Return
RG
Rakuten Group Setagaya-Ku, Tokyo, Japan $2.58B AUM 250.19% 1-Year Est. Return
GFA
Gallagher Fiduciary Advisors Rolling Meadows, Illinois $2.58B AUM 8.97% 1-Year Est. Return
LS
Livforsakringsbolaget Skandia Stockholm, Sweden $2.58B AUM 30.64% 1-Year Est. Return
HWA
Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return
AAS
Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return

Chesley Taft & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Chesley Taft & Associates held 258 positions worth $967M, up 3.7% from $933M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Chesley Taft & Associates's Q2 2014 filing shows 9 new, 107 increased, 75 reduced and 9 closed positions. Its largest new stake was NXP Semiconductors: 117,465 shares worth $7.77M. The largest sale was CR Bard Inc., an estimated $7.68M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.

  • Chesley Taft & Associates's largest Q2 2014 buy was NXP Semiconductors: 117,465 shares worth $7.77M.
  • Chesley Taft & Associates added most to Celgene Corp in Q2 2014, an estimated $12.7M increase.
  • Chesley Taft & Associates's biggest Q2 2014 reduction was Coca-Cola, cutting an estimated $6.98M.
  • Chesley Taft & Associates fully exited CR Bard Inc. in Q2 2014, selling an estimated $7.68M.
  • Chesley Taft & Associates's ten largest holdings make up 21% of its $967M portfolio in Q2 2014.
  • Chesley Taft & Associates opened 9 new positions and closed 9 in Q2 2014.
  • Chesley Taft & Associates's portfolio value rose 3.7% quarter-over-quarter to $967M.

Based on Chesley Taft & Associates's 13F filing for Q2 2014, filed 17 Jul 2014.